Alberto Padron, MD
Surgery · Orlando, FLNPI 1609978089
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (48.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. Covidien LP accounts for 90.2% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $9,187 and has fallen 98.7% since, to $118 in 2025.
Across 52 payments — averaging $194.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Covidien LP$9K
- Heron Therapeutics, Inc.$175
- Innocoll Pharmaceuticals Limited$169
- Globus Medical$154
- CSL Behring$104
- AbbVie$97
- plus $293 from 11 others
What the payments were for
- Consulting fees$4,90048%
- Speaking & faculty fees$3,75037%
- Travel & lodging$681%
- Food & beverage$1,41314%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Covidien LP | 20 | $9,139 |
| Heron Therapeutics, Inc. | 5 | $175 |
| Innocoll Pharmaceuticals Limited | 3 | $169 |
| Globus Medical | 1 | $154 |
| CSL Behring | 1 | $104 |
| AbbVie(2 entities) | 6 | $97 |
| Kowa Pharmaceuticals America, Inc. | 3 | $66 |
| Smith+Nephew | 3 | $44 |
| Pacira Pharmaceuticals Incorporated | 2 | $32 |
| Livanova USA, Inc. | 1 | $26 |
| Arthrex | 1 | $24 |
| Innovation Technologies Inc | 1 | $24 |
| Johnson & Johnson | 1 | $17 |
| Checkpoint Surgical, Inc | 1 | $17 |
| Novartis | 1 | $16 |
| Angiodynamics, Inc. | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,131 in reported general payments places this provider in the 70th percentile of 1,569 surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 132 | $722 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 38 | $177 |
| Tramadol Hcl | 21 | $57 |
Paid to pharmacies, not to this prescriber.
Other surgery in Orlando
- Juan EscalonOrlando$355K
- Hany TaklaOrlando$176K
- Eleftherios MamounasOrlando$166K
- Gustavo Bello-VincentelliOrlando$117K
- Jorge FlorinWinter Garden$2.2M
- Amit TaggarTampa$1.4M
- Keith KimCelebration$1.1M
- Richard DiciccoTampa$964K
- Elizabeth DovecLakeland$870K
- Christopher DucoinTampa$808K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.